XML 49 R31.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

RESTRUCTURING (Tables) | 12 Months Ended
--- | ---
Mar. 30, 2024
Restructuring and Related Activities [Abstract] |
Schedule of Restructuring and Transformation Costs by Type of Cost | The following table summarizes the activity for restructuring reserves related to portfolio rationalization initiatives, the 2020 Program and prior programs for the fiscal years ended March 30, 2024, April 1, 2023 and April 2, 2022, substantially all of which relates to employee severance and other employee costs:
(In thousands) | Portfolio Rationalization |  | 2020 Program |  | Prior Programs |  | Total
Balance at April 3, 2021 | $ | — |  |  | $ | 575 |  |  | $ | 437 |  |  | $ | 1,012 |
Costs incurred, net of reversals | — |  |  | 4,202 |  |  | 28 |  |  | 4,230 |
Payments | — |  |  | (2,317) |  |  | (120) |  |  | (2,437) |
Balance at April 2, 2022 | $ | — |  |  | $ | 2,460 |  |  | $ | 345 |  |  | $ | 2,805 |
Costs incurred, net of reversals | — |  |  | 576 |  |  | 81 |  |  | 657 |
Payments | — |  |  | (1,226) |  |  | (86) |  |  | (1,312) |
Balance at April 1, 2023 | $ | — |  |  | $ | 1,810 |  |  | $ | 340 |  |  | $ | 2,150 |
Costs incurred, net of reversals | 13,915 |  |  | 450 |  |  | (276) |  |  | 14,089 |
Payments | (2,606) |  |  | (1,775) |  |  | (64) |  |  | (4,445) |
Balance at March 30, 2024 | 11,309 |  |  | 485 |  |  | — |  |  | 11,794 |
The following presents the restructuring costs by line item during fiscal 2024, 2023 and 2022 within our accompanying consolidated statements of income and comprehensive income:
(In thousands) | 2024 |  | 2023 |  | 2022
Cost of goods sold | $ | 11,286 |  |  | $ | (215) |  |  | $ | 2,236 |
Research and development | 456 |  |  | — |  |  | 105 |
Selling, general and administrative expenses | 2,347 |  |  | 872 |  |  | 1,889 |
Total | $ | 14,089 |  |  | $ | 657 |  |  | $ | 4,230 |
Restructuring and Related Costs by Segment | The following presents the restructuring related costs by line item during fiscal 2024, 2023 and 2022 within our accompanying consolidated statements of income and comprehensive income:
(In thousands) | 2024 |  | 2023 |  | 2022
Cost of goods sold | $ | 5,734 |  |  | $ | 7,991 |  |  | $ | 17,832 |
Research and development | 1,750 |  |  | 1,050 |  |  | 714 |
Selling, general and administrative expenses | 2,015 |  |  | 1,851 |  |  | 6,048 |
Total | $ | 9,499 |  |  | $ | 10,892 |  |  | $ | 24,594 |
The tables below present restructuring and restructuring related costs by reportable segment:
Restructuring costs |  |  |  |  |
(In thousands) | 2024 |  | 2023 |  | 2022
Plasma | $ | 1,015 |  |  | $ | (48) |  |  | $ | 2,492 |
Blood Center | 5,606 |  |  | — |  |  | (18) |
Hospital | 3,863 |  |  | 165 |  |  | (93) |
Corporate | 3,605 |  |  | 540 |  |  | 1,849 |
Total | $ | 14,089 |  |  | $ | 657 |  |  | $ | 4,230 |
Restructuring related costs |  |  |  |  |
(In thousands) | 2024 |  | 2023 |  | 2022
Plasma | $ | 1,050 |  |  | $ | 1,385 |  |  | $ | 7,906 |
Blood Center | 286 |  |  | 75 |  |  | 556 |
Hospital | 408 |  |  | 546 |  |  | 379 |
Corporate | 7,755 |  |  | 8,886 |  |  | 15,753 |
Total | $ | 9,499 |  |  | $ | 10,892 |  |  | $ | 24,594 |
Total restructuring and restructuring related costs | $ | 23,588 |  |  | $ | 11,549 |  |  | $ | 28,824 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration